Document:

exhibit10_1.htm

Exhibit 10.1

CONSULTING, CONFIDENTIALITY AND PROPRIETARY RIGHTS AGREEMENT

This Consulting, Confidentiality and Proprietary Rights Agreement ("Agreement") is entered into as of the 31st day of January, 2011 (the “Effective Date”) by and between Green Star Alternative Energy, Inc. (the “Company”), and Eric Stoppenhagen(“Consultant”).

WHEREAS, the Company desires to engage Consultant to provide certain services as set forth on Schedule attached hereto and as specified from time to time by the Company.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and conditions contained herein, the parties hereto agree as follows:

1.  Engagement.  The Company hereby engages Consultant to perform, those duties set forth in the Schedule attached hereto and such other duties as may be requested from time to time by the Board of Directors of the Company. Consultant hereby accepts such engagement upon the terms and subject to conditions set forth in this Agreement.

2.  Compensation.  For the services rendered by Consultant under this Agreement, the Company shall pay to Consultant the compensation specified in the Schedule which shall include travel time, subject to the terms and conditions set forth in this Agreement.

3.  Term and Survivability.  The term of this Agreement shall be for a period from the Effective Date to December 31, 2011.  In addition, this Agreement may be terminated if either party materially fails to perform or comply with this Agreement or any material provision hereof. Termination shall be effective five (5) days after notice of such material failure to perform or comply with this Agreement or any material provision hereof to the defaulting party if the defaults have not been cured within such five (5) day period.  In the event, Consultant is compelled to spend time as relates to his duties under this Agreement after the termination of this Agreement, the Consultant shall be paid at a rate of $350 per hour. Upon termination of this Agreement the following sections of this Agreement shall survive such termination:  Sections 3, 5, 6, 7, 8, 10, 12 13 and 20.

4.  Costs and Expenses of Consultant’s Performance.  Except as set forth on the Schedule, all costs and expenses of Consultant’s performance hereunder shall be borne by the Consultant.

5.  Taxes.  As an independent contractor, Consultant acknowledges and agrees that it is solely responsible for the payment of any taxes and/or assessments imposed on account of the payment of compensation to, or the performance of services by Consultant pursuant to this Agreement, including, without limitation, any unemployment insurance tax, federal and state income taxes, federal Social Security (FICA) payments, and state disability insurance taxes. The Company shall not make any withholdings or payments of said taxes or assessments with respect to amounts paid to Consultant hereunder; provided, however, that if required by law or any governmental agency, the Company shall withhold such taxes or assessments from amounts due Consultant, and any such withholding shall be for Consultant's account and shall not be reimbursed by the Company to Consultant. Consultant expressly agrees to make all payments of such taxes, as and when the same may become due and payable with respect to the compensation earned under this Agreement.

6.  Confidentiality.  Consultant agrees that Consultant will not, except when required by applicable law or order of a court, during the term of this Agreement or thereafter, disclose directly or indirectly to any person or entity, or copy, reproduce or use, any Trade Secrets (as defined below) or Confidential Information (as defined below) or other information treated as confidential by the Company known, learned or acquired by the Consultant during the period of the Consultant's engagement by the Company.  For purposes of this Agreement, "Confidential Information" shall mean any and all Trade Secrets, knowledge, data or know-how of the Company, any of its affiliates or of third parties in the possession of the Company or any of its affiliates, and any nonpublic technical, training, financial and/or business information treated as confidential by the Company or any of its affiliates, whether or not such information, knowledge, Trade Secret or data was conceived, originated, discovered or developed by Consultant hereunder.  For purposes of this Agreement, "Trade Secrets" shall include, without limitation, any formula, concept, pattern, processes, designs, device, software, systems, list of customers, training manuals, marketing or sales or service plans, business plans, marketing plans, financial information, or compilation of information which is used in the Company's business or in the business of any of its affiliates.  Any information of the Company or any of its affiliates which is not readily available to the public shall be considered to be a Trade Secret unless the Company advises Consultant in writing otherwise. Consultant acknowledges that all of the Confidential Information is proprietary to the Company and is a special, valuable and unique asset of the business of the Company, and that Consultant's past, present and future engagement by the Company has created, creates and will continue to create a relationship of confidence and trust between the Consultant and the Company with respect to the Confidential Information.  Furthermore, Consultant shall immediately notify the Company of any information which comes to its attention which might indicate that there has been a loss of confidentiality with respect to the Confidential Information. In such event, Consultant shall take all reasonable steps within its power to limit the scope of such loss.

7.    Return of the Company’s Proprietary Materials.  Consultant agrees to deliver promptly to the Company on termination of this Agreement for whatever reason, or at any time the Company  may so request, all documents, records, artwork, designs, data, drawings, flowcharts, listings, models, sketches, apparatus, notebooks, disks, notes, copies and similar repositories of Confidential Information and any other documents of a confidential nature belonging to the Company, including all copies, summaries, records, descriptions, modifications, drawings or adaptations of such materials which Consultant may then possess or have under its control.  Concurrently with the return of such proprietary materials to the Company, Consultant agrees to deliver to the Company such further agreements and assurances to ensure the confidentiality of proprietary materials.  Consultant further agrees that upon termination of this Agreement, Consultant's, employees, consultants, agents or independent contractors shall not retain any document, data or other material of any description containing any Confidential Information or proprietary materials of the Company.

8.   Assignment of Proprietary Rights.  Other than the Proprietary Rights listed on the Schedule attached hereto, if any, Consultant hereby assigns and transfers to the Company all right, title and interest that Consultant may have, if any, in and to all Proprietary Rights (whether or not patentable or copyrightable) made, conceived, developed, written or first reduced to practice by Consultant, whether solely or jointly with others, during the period of Consultant's engagement by the Company which relate in any manner to the actual or anticipated business or research and development of the Company, or result from or are suggested by any task assigned to Consultant or by any of the work Consultant has performed or may perform for the Company.

Consultant acknowledges and agrees that the Company shall have all right, title and interest in, among other items, all research information and all documentation or manuals related thereto that Consultant develops or prepares for the Company during the period of Consultant's engagement by the Company and that such work by Consultant shall be work made for hire and that the Company shall be the sole author thereof for all purposes under applicable copyright and other intellectual property laws. Other than the Proprietary Rights listed on the Schedule attached hereto, Consultant represents and covenants to the Company that there are no Proprietary Rights relating to the Company's business which were made by Consultant prior to Consultant's engagement by the Company. Consultant agrees promptly to disclose in writing to the Company all Proprietary Rights in order to permit the Company to claim rights to which it may be entitled under this Agreement.  With respect to all Proprietary Rights which are assigned to the Company pursuant to this Section 8, Consultant will assist the Company in any reasonable manner to obtain for the Company's benefit patents and copyrights thereon in any and all jurisdictions as may be designated by the Company, and Consultant will execute, when requested, patent and copyright applications and assignments thereof to the Company, or other persons designated by the Company, and any other lawful documents deemed necessary by the Company to carry out the purposes of this Agreement. Consultant will further assist the Company in every way to enforce any patents, copyrights and other Proprietary Rights of the Company.

9.  Trade Secrets of Others.  Consultant represents to the Company that its performance of all the terms of this Agreement does not and will not breach any agreement to keep in confidence proprietary information or trade secrets acquired by Consultant in confidence or in trust prior to its engagement by the Company, and Consultant will not disclose to the Company, or induce the Company to use, any confidential or proprietary information or material belonging to others. Consultant agrees not to enter into any agreement, either written or oral, in conflict with this Agreement.

10.  Other Obligations.  Consultant acknowledges that the Company, from time to time, may have agreements with other persons which impose obligations or restrictions on the Company regarding proprietary rights made or developed during the course of work hereunder or regarding the confidential nature of such work. Consultant agrees to be bound by all such obligations and restrictions and to take all action necessary to discharge the obligations of the Company hereunder.

11.  Independent Contractor.  Consultant shall not be deemed to be an employee or agent of the Company for any purpose whatsoever. Consultant shall have the sole and exclusive control over its employees, consultants or independent contractors who provide services to the Company, and over the labor and employee relations policies and policies relating to wages, hours, working conditions or other conditions of its employees, consultants or independent contractors.

12. Non-Solicit. Consultant and the Company will not, during the term this Agreement and for one year thereafter, directly or indirectly (whether as an owner, partner, shareholder, agent, officer, director, employee, independent contractor, consultant, or otherwise) with or through any individual or entity: (i) employ, engage or solicit for employment any individual who is, or was at any time during the twelve-month period immediately prior to the termination of this Agreement for any reason, an employee of the other party, or otherwise seek to adversely influence or alter such individual's relationship with the other party; or (ii) solicit or encourage any individual or entity that is, or was during the twelve-month period immediately prior to the termination of this Agreement for any reason, a customer or vendor of the other party to terminate or otherwise alter his, her or its relationship with the other party or any of its affiliates.  Section 12 does not apply to individuals or entities known to the Consultant previous to the Effective Date.

13. Equitable Remedies.  In the event of a breach or threatened breach of the terms of this Agreement by Consultant, the parties hereto acknowledge and agree that it would be difficult to measure the damage to the Company from such breach, that injury to the Company from such breach would be impossible to calculate and that monetary damages would therefore be an inadequate remedy for any breach. Accordingly, the Company, in addition to any and all other rights which may be available, shall have the right of specific performance, injunctive relief and other appropriate equitable remedies to restrain any such breach or threatened breach without showing or proving any actual damage to the Company.

14. Governing Law.  This Agreement shall be governed, construed and interpreted in accordance with the internal laws of the State of California. In the event a judicial proceeding is necessary, the sole forum for resolving disputes arising under or relating to this Agreement are the Municipal and Superior Courts for the County of Orange, California or the Federal District Court for the Central District of California and all related appellate courts, and the parties hereby consent to the jurisdiction of such courts, and that venue shall be in Orange County, California.

15.  Entire Agreement: Modifications and Amendments.  The terms of this Agreement are intended by the parties as a final expression of their agreement with respect-to such terms as are included in this Agreement and may not be contradicted by evidence of any prior or contemporaneous agreement. The Schedule referred to in this Agreement is incorporated into this Agreement by this reference. This Agreement may not be modified, changed or supplemented, nor may any obligations hereunder be waived or extensions of time for performance granted, except by written instrument signed by the parties or by their agents duly authorized in writing or as otherwise expressly permitted herein.

16.  Attorneys Fees.  Should any party institute any action or proceeding to enforce this Agreement or any provision hereof, or for damages by reason of any alleged breach of this Agreement or of any provision hereof, or for a declaration of rights hereunder, the prevailing party in any such action or proceeding shall be entitled to receive from the other party all costs and expenses, including reasonable attorneys' fees, incurred by the prevailing party in connection with such action or proceeding.

17. Prohibition of Assignment.  This Agreement and the rights, duties and obligations hereunder may not be assigned or delegated by Consultant without the prior written consent of the Company. Any assignment of rights or delegation of duties or obligations hereunder made without such prior written consent shall be void and of no effect.

18.  Binding Effect: Successors and Assignment.  This Agreement and the provisions hereof shall be binding upon each of the parties, their successors and permitted assigns.

19.  Validity.  This Agreement is intended to be valid and enforceable in accordance with its terms to the fullest extent permitted by law. If any provision of this Agreement is found to be invalid or unenforceable by any court of competent Jurisdiction, the invalidity or unenforceability of such provision shall not affect the validity or enforceability of all the remaining provisions hereof.

20. Indemnification.  The Company shall indemnify, defend and hold harmless Consultant from and against any and all liability, loss, damage, expense, claims or suits arising out of: (i) Company’s breach of this Agreement, including any representations warranty contained herein; or (ii) the Services provided by Consultant, provided such claim does not in any manner arise from Consultant’s grossly negligent or willful act or omission. Additionally, Consultant will be covered under the Director’s and Officer’s policy of the Company.  The Company will provide evidence of coverage to the Consultant which shall be a minimum of one million dollar coverage paid in full for the year. 

21.  Notices.  All notices and other communications hereunder shall be in writing and, unless otherwise provided herein, shall be deemed duly given if delivered personally or by telecopy or mailed by registered or certified mail (return receipt requested) or by Federal Express or other similar courier service to the parties at the following addresses or (at such other address for the party as shall be specified by like notice)

(i)  If to the Company:

Office:

Fax:

(ii) If to the Consultant:

Any such notice, demand or other communication shall be deemed to have been given on the date personally delivered or as of the date mailed, as the case may be.

 

IN WITNESS WHEREOF, the parties hereto have executed this Consulting, Confidentiality, and Proprietary Rights Agreement as of the Effective Date written above.

Eric Stoppenhagen

Consultant

By: ___/s/ Eric Stoppenhagen___________

	
  

	 	
Eric Stoppenhagen

Green Star Alternative Energy, Inc.

The Company

By: ___/s/ Eric Stoppenhagen ___________

	
  

	 	
Name:

	
Eric Stoppenhagen

	
  

	
Title: Chairman of the BoardExhibit 10.2 - Exclusive Technology License and Patents Agreement
between EnzymeBioSystems and Berkeley Clinic LC, dated January 28, 2011

                       EXCLUSIVE TECHNOLOGY LICENSE
                                    AND
                             PATENTS AGREEMENT

   THIS AGREEMENT, effective January 28, 2011, is entered into by Berkeley
Clinic LC, an Arizona Limited Liability Company (herein called "LICENSEE")
and EnzymeBioSystems (herein called "LICENSOR").

                                 ARTICLE I
                          BACKGROUND OF AGREEMENT

   LICENSOR represents that it is the owner of the right to file PATENTS
and IMPROVEMENTS, PROPRIETARY INFORMATION, TRADE SECRETS, TECHNICAL and
SCIENTIFIC information and KNOW-HOW, all pertaining to the development of all
enzyme products (herein called TECHNOLOGY).  LICENSOR desires to grant an
exclusive fifty (50) percent ownership and one million Series A Preferred
shares of EnzymeBioSystems to LICENSEE and assign all rights, title and
interest in all foreign patents granted at a future date, subject to certain
terms and conditions in exchange for One Hundred Fifty Thousand ($150,000)
Dollars.

   1.01  LICENSEE wishes to acquire an exclusive license pursuant to the
issuance of future domestic and foreign PATENTS and IMPROVEMENTS, PROPRIETARY
INFORMATION, TRADE SECRETS, TECHNICAL and SCIENTIFIC information, KNOW-HOW
and registered TRADEMARKS of LICENSOR for purposes of making, using and
selling the TECHNOLOGY on a foreign basis developed by the LICENSOR.

   1.02  LICENSEE wishes to acquire fifty (50) percent all rights, title and
interest in all domestic and foreign patents filed as of the date of this
agreement that related to the TECHNOLOGY and any foreign patents filed and
granted in the future by the LICENSOR, including all improvements on foreign
patents filed or to be filed in the future, pursuant to certain
considerations in the form of a Product Royalty to be paid to the LICENSOR,
by the LICENSEE or SUBLICENSES.

                                 ARTICLE II
                                 DEFINITIONS

As used herein, the following terms shall have the meanings set forth below:

   2.00  CONFIDENTIAL INFORMATION is that information that is transmitted by
LICENSOR and received by LICENSEE that is considered by LICENSOR to be
CONFIDENTIAL and PROPRIETARY INFORMATION.

   2.01  EFFECTIVE DATE shall be January 28, 2011.

   2.02  KNOW-HOW means that special knowledge, skill and experience, as
applied to the LICENSED PRODUCT and the LICENSED PROCESS and TECHNOLOGY, that
is possessed by the LICENSOR that is PROPRIETARY or CONFIDENTIAL INFORMATION.

   2.03  LICENSED FIELD means, and is limited to, the practice of PATENT(S)
and IMPROVEMENTS, PATENTS that may issue in the future, PROPRIETARY
INFORMATION, TRADE SECRETS, TECHNICAL and SCIENTIFIC information and KNOW-HOW
for purposes of using the LICENSED PRODUCT and the LICENSED TECHNOLOGY on an
exclusive worldwide basis.

   2.04  LICENSED PRODUCTS or DESIGNS means any and all products which
fall within the LICENSED FIELD and which are covered by, marked or are
produced using a process or method covered by a claim of a PATENT(S) and
IMPROVEMENTS, PROPRIETARY INFORMATION, TRADE SECRETS, TECHNICAL and
SCIENTIFIC information and KNOW-HOW of LICENSOR for purposes of commercially
using the LICENSED TECHNOLOGY.

   2.05  LICENSED PROCESS AND TECHNOLOGY means any and all process or
proprietary technology, engineering and design features or components which
fall within the LICENSED FIELD which were developed by the LICENSOR or his
affiliates and which are covered by, marked or are produced using a process
or method covered by a claim of a PATENT(S) and IMPROVEMENTS, PROPRIETARY
INFORMATION, TRADE SECRETS, TECHNICAL and SCIENTIFIC information and KNOW-HOW
of LICENSOR for purposes of commercially utilizing the LICENSED PRODUCT.

   2.06  LICENSED TERRITORY shall mean all countries of the world.

   2.07  LICENSEE means Berkeley Clinic LC. an Arizona Limited Liability
Company.

   2.08  LICENSOR means EnzymeBioSystems, a Nevada Corporation.

   2.09  PATENT(S), PROVISIONAL PATENT(S) or PATENT APPLICATION(S)
means any PATENT(S) granted or PATENT APPLICATION(S) made by LICENSOR
pursuant thereto, and all divisions, continuations, continuations in part,
reissues, substitutes, and extensions thereof.

   2.10  PROPRIETARY INFORMATION means all information possessed by the
LICENSOR that is CONFIDENTIAL in nature and that the LICENSOR has exclusive
rights in and to. It includes TRADE SECRETS, TECHNICAL and SCIENTIFIC
information, and KNOW-HOW as related to the LICENSED PRODUCTS and the
LICENSED TECHNOLOGY.

   2.11  TECHNICAL and SCIENTIFIC information means all PROPRIETARY
INFORMATION, TRADE SECRETS, KNOW-HOW and all information contained in
PATENT(S) that may issue or PATENT APPLICATION(S) and IMPROVEMENTS that is
the exclusive property of LICENSOR developed or acquired as of the date of
this agreement which would be useful in the making, using and selling of the
LICENSED PRODUCTS in the LICENSED TERRITORY.

   2.12  TRADE SECRET means any CONFIDENTIAL INFORMATION that is the
personal property of LICENSOR and in which he has an exclusive right.

                                 ARTICLE III
                                LICENSE GRANT

   3.00  LICENSOR hereby grants to LICENSEE, a license under any PATENT(S)
or PATENT APPLICATION(S) to be filed and IMPROVEMENTS, PROPRIETARY
INFORMATION including TRADE SECRETS, TECHNICAL and SCIENTIFIC information,
and KNOW-HOW for the purpose of using the LICENSED PRODUCTS and the LICENSED
PROCESS and TECHNOLOGY, specifically the development of enzyme related
products, not limited but including any product developed and researched at
Northeastern Ohio Universities Colleges of Medicine and Pharmacy, 4209 State
Route 44, Rootstown, Ohio 44272.

        (a)  The Parties agree that any IMPROVEMENTS, design changes,
modifications or developments of the LICENSED PRODUCT or the LICENSED
TECHNOLOGY, made by LICENSOR shall be available to LICENSEE in the LICENSED
TERRITORY at no additional cost.  In the event LICENSOR makes application for
any new patent, LICENSEE shall have the right to use and purchase for $1.00
and other good and valuable consideration, fifty (50) percent ownership in
any newly developed product, process or technology under this Agreement.

        (b)  The Parties further agree that any IMPROVEMENTS, design changes,
modifications or developments of the LICENSED PRODUCT or LICENSED TECHNOLOGY
made by LICENSEE, which may be patented, may be made or used in the LICENSED
TERRITORY by the LICENSEE. LICENSEE shall promptly inform LICENSOR of any
such IMPROVEMENTS or of the filing of any patent applications by LICENSEE.
LICENSEE shall grant to LICENSOR, for no consideration, and on a ROYAL free
basis, an exclusive license on a foreign basis (i.e, outside the USA).  Any
IMPROVEMENTS, design changes, modifications or developments of the LICENSED
PRODUCT or LICENSED TECHNOLOGY by LICENSEE are construed to be a part of this
Agreement and LICENSEE shall be bound to all terms and conditions contained
in this Agreement.

   3.01  LICENSOR further grants to LICENSEE, to the extent of the LICENSED
FIELD and LICENSED TERRITORY, a license to use any registered TRADEMARK,
owned, acquired, developed or filed for by the LICENSOR, relating to the
LICENSED PRODUCT or LICENSED PROCESS and TECHNOLOGY.

   3.02  The PRODUCT LICENSE granted pursuant to Sections 3.00 and 3.01 shall
be exclusive, with the right to grant EXCLUSIVE SUBLICENSES thereafter for
the term of this Agreement as defined in Article VI. Such approval shall not
be unreasonably withheld. Any EXCLUSIVE SUBLICENSE agreement of LICENSEE
shall be bound by all terms of this Agreement, unless expressly excluded in
writing, by LICENSOR.

                                 ARTICLE IV
                            PAYMENTS FOR PATENTS

   4.00  LICENSEE shall, on or about February 1, 2011, as a one time only
LICENSEE FEE, pay to LICENSOR, as consideration One Hundred Fifty Thousand
($150,000) Dollars, of which Fifty Thousand ($50,000) Dollars has already
been paid, to purchase 1,000,000 shares of the LICSENSOR'S Series A
Designated Preferred Stock and fifty (50) percent ownership, in perpetuity,
in EnzymeBioSystems' international Patents and intellectual property.

                                ARTICLE V
               RIGHT TO PURCHASE PATENTS AT THE TIME OF GRANT

   5.00  In the event the LICENSOR is granted foreign patents issued in
the future, the LICENSOR hereby agree that within Sixty (60) days they will
execute any and all documents necessary to legally assign or transfer all
right, title and interest of the PATENTS to the LICENSEE for One Dollar
($1.00) and other good and valuable consideration.  It being understood that
so long as this AGREEMENT remains in good standing, the LICENSOR agrees to
assume financial responsibility to pay directly all costs related preparing
and prosecution patent applications on behalf of the LICENSEE, including but
not limited to legal fees, filing fees, maintenance fees and translation
costs.

                                  ARTICLE VI
                                  EXPORTATION

   6.00  LICENSEE shall be limited to the use of the LICENSED PRODUCT or
LICENSED PROCESS and TECHNOLOGY in the LICENSED FIELD to the LICENSED
TERRITORY. LICENSEE shall not export the LICENSED PRODUCT or LICENSED PROCESS
and TECHNOLOGY to countries or territories that would be deemed to be high
risk with regard to utilizing the technology without legal authorization.
Any country to which the LICENSEE proposes to grant SUBLICENSES to, must have
without written authorization and consent from the LICENSOR.

   6.01  SUBLICENSE agreements shall be limited to the use of the LICENSED
PRODUCT or LICENSED TECHNOLOGY in the LICENSED FIELD to the LICENSED
TERRITORY. SUBLICENSEE(S) shall not export LICENSED PRODUCT or LICENSED
TECHNOLOGY to any customer in any country or territory without written
notification to and receipt of written authorization and consent from
LICENSOR.

   6.02  In the event the LICENSEE grants and executes a SUBLICENSE agreement
that is approved by LICENSOR, it is understood that all proprietary
components of the LICENSED PRODUCT shall be purchase exclusively through the
LICENSEE or the LICENSOR.

                                ARTICLE VII
                              CONFIDENTIALITY

   7.00  LICENSEE, LICENSEE'S employees and SUBLICENSEES shall not disclose,
by any method of communication, any PROPRIETARY INFORMATION, TRADE SECRETS,
TECHNICAL and SCIENTIFIC information, KNOW-HOW or other CONFIDENTIAL
INFORMATION expressly or implied disclosed by LICENSOR to LICENSEE without
the expressed written permission of LICENSOR.

   7.01  Any SUBLICENSE Agreement of LICENSEE shall incorporate and contain
the terms of Article VI and VII of this Agreement and any SUBLICENSE shall
sign a separate Confidentiality Agreement with LICENSEE relative to
PROPRIETARY and CONFIDENTIAL INFORMATION received as the result of this
Agreement.

                                ARTICLE VIII
                               PRIVATE LABELS

   8.00  All LICENSED PRODUCT used pursuant to this LICENSE AGREEMENT,
may be used under any TRADEMARK(S) developed or owned by the LICENSOR or a
TRADEMARK developed and owned by the LICENSEE.  In the event that any
TRADEMARK utilized by the LICENSEE, is in conflict with another company
operating within any country in the TERRITORY, any other such PRIVATE LABEL
selected by LICENSEE or SUBLICENSEE may be used.

   8.01  The PRIVATE LABEL of the LICENSED PRODUCT shall comply with the
appropriate regulations of all governmental agencies of the country within
the TERRITORY.

   8.02  As long as this exclusive LICENSEE AGREEMENT or any modification or
extension thereof remains in force and effect, LICENSEE shall own each such
PRIVATE LABEL or trademark to be used exclusively by LICENSEE on LICENSED
PRODUCT.

                                  ARTICLE IX
                REPRESENTATIONS AND DISCLAIMER OF WARRANTIES

   9.00  NOTHING IN THIS AGREEMENT SHALL BE DEEMED TO BE A REPRESENTATION OR
WARRANTY BY LICENSOR OF THE VALIDITY OF ANY PATENTS, PATENTS THAT MAY ISSUE,
PATENT APPLICATIONS AND IMPROVEMENTS, PROPRIETARY KNOWLEDGE, TRADE SECRETS,
TECHNICAL AND SCIENTIFIC INFORMATION, KNOW-HOW AND REGISTERED TRADEMARKS
LICENSOR SHALL HAVE NO LIABILITY WHATSOEVER TO LICENSEE OR ANY OTHER PERSON
FOR, OR ON ACCOUNT OF ANY INJURY, LOSS OR DAMAGE OF ANY KIND OR NATURE,
SUSTAINED BY, OR ANY DAMAGE ASSESSED OR ASSERTED AGAINST, OR ANY OTHER
LIABILITY INCURRED BY OR IMPOSED UPON LICENSEE OR ANY OTHER PERSON, ARISING
OUT OF OR IN CONNECTION WITH, OR RESULTING FROM:

        (a)  THE PRODUCTION, USE OR SALE OF ANY APPARATUS OR PRODUCT, OR THE
PRACTICE OF ANY PATENTS THAT MAY ISSUE, PATENT APPLICATIONS OR IMPROVEMENTS;
OR
        (b)  ANY ADVERTISING OR OTHER PROMOTIONAL ACTIVITIES WITH RESPECT TO
ANY OF THE FOREGOING.
        (c)  LICENSEE SHALL HOLD LICENSOR, AND ITS PARTNERS, AGENTS OR
EMPLOYEES HARMLESS IN THE EVENT LICENSOR, OR ITS OFFICERS, AGENTS OR
EMPLOYEES, IS HELD LIABLE.

   9.01  LICENSOR shall have the right to file, prosecute and maintain PATENT
APPLICATIONS and IMPROVEMENTS that are the property of LICENSOR and shall
have the right to determine whether or not, and where to file a patent
application or to abandon the prosecution of any patent or patent
application.

                                  ARTICLE X
                                 TERMINATION

   10.00  This Agreement shall terminate:

        (a)  upon termination of this Agreement, the PRODUCT ROYALTY shall
continue in perpetuity.
        (b)  if the one time only License Fee totaling $150,000 is not paid
on or before February 29, 2011.

   10.01  LICENSEE may terminate this Agreement at any time upon sixty (60)
days written notice in advance to LICENSOR.

If either party shall be:
        (a)  in default of any obligation hereunder; or
        (b)  shall be adjudged bankrupt; or shall become insolvent; or
        (c)  shall make an assignment of this Agreement to a third party.

   10.03  The word "termination" and cognate words, such as "term" and
"terminate", used in Article XII and elsewhere in this agreement, are to
read, except where the contrary is specifically indicated, as omitting from
their effect, the following rights and obligations, all of which survive any
termination to the degree necessary to permit their complete fulfillment or
discharge:

   (a)  LICENSOR'S obligation to supply a terminal report as specified in
paragraph 10.02 of this Agreement;
   (b)  LICENSOR'S obligation to maintain records under Section under 15.00
of this Agreement;
   (c)  licenses, releases and agreements of nonassertion running in favor of
customers or transferees of LICENSOR in respect to products sold or
transferred by LICENSOR prior to any termination and on which ROYALTIES shall
have been paid as provided in paragraph 4.01 of this Agreement;
   (d)  any cause of action or claim of LICENSEE accrued or to accrue,
because of any breach or default by LICENSOR.

                                  ARTICLE XI
                                  ARBITRATION

   11.00  Any controversy or dispute arising out of or in connection with
this Agreement, its interpretation, performance, or termination, which the
parties are unable to resolve within a reasonable time after written notice
by one party to the other of the existence of such controversy or dispute,
may be submitted to arbitration by either party and if so submitted by either
party, shall be finally settled by arbitration conducted in accordance with
the rules of conciliation and arbitration of the Chamber of Commerce in
effect on the date hereof. Any such arbitration shall take place in the City
of Las Vegas, Nevada. Such arbitration shall be conducted in the English
language and the arbitrators shall apply the laws of the Country of the
United States.

   11.01  The institution of any arbitration proceeding hereunder shall not
relieve LICENSEE of its obligation to make payments accrued hereunder
pursuant to Sections 4.00 hereof to LICENSOR during the continuance of such
proceeding. The decision by the arbitrators shall be binding and conclusive
upon the parties, their successors, and assigns and they shall comply with
such decision in good faith, and each party hereby submits itself to the
jurisdiction of the courts of the place where the arbitration is held, but
only for the entry judgment with respect to the decision of the arbitrators
hereunder. Notwithstanding the foregoing, judgment upon award may be entered
in any court where the arbitration takes place, or any court having
jurisdiction.

                                 ARTICLE XII
                                 LITIGATION

   12.00  Each party shall notify the other party in writing of any suspected
infringement(s) of any PATENT(S) or PATENT(S) that may issue, PATENT
APPLICATIONS and IMPROVEMENTS, PROPRIETARY INFORMATION, TRADE SECRETS,
TECHNICAL and SCIENTIFIC information, KNOW-HOW and registered TRADEMARKS in
the LICENSED TERRITORY, and shall inform the other party of any evidence of
such infringement(s).

   12.01  LICENSOR shall have the first right to institute suit for
infringement(s) in the LICENSED FIELD and the LICENSED TERRITORY. LICENSEE
agrees to join as a party plaintiff in any such lawsuit initiated by
LICENSOR, if requested by LICENSOR, with all costs, attorney fees, and
expenses to be paid by LICENSOR.  However, if LICENSEE does not institute
suit for infringement(s) within ninety (90) days of receipt of written notice
from LICENSEE of LICENSOR'S desire to bring suit for infringement in its own
name and on its own behalf, then LICENSEE may, at its own expense, bring suit
or take any other appropriate action.

   12.02  If this Agreement is non-exclusive at the time of infringement(s),
the sole right to institute suit for infringement and to recover damages
shall rest with LICENSOR. damages resulting from any lawsuit brought by
LICENSOR to enforce any patent that my issue pursuant to paragraph 12.01.

   12.04  Either party may settle with an infringer without the prior
approval of the other party if such settlement would not affect the rights of
the other party under any patent that may issue, PATENT APPLICATIONS and
IMPROVEMENTS, PROPRIETARY INFORMATION, TRADE SECRETS, TECHNICAL and
SCIENTIFIC information, KNOW-HOW and registered TRADEMARKS.

   12.05  Any SUBLICENSE agreement of LICENSEE shall incorporate and contain
the terms of Article XII of this Agreement.

                                ARTICLE XIII
                                   RECORDS

   13.00  LICENSOR shall keep accurate records of all operations affecting
payments hereunder, and shall permit LICENSEE or its duly authorized agent to
inspect all such records and to make copies of or extracts from such records
during regular business hours throughout the term of this Agreement and for a
reasonable period of not less than three (3) years thereafter.

   13.01  Any SUBLICENSE agreement of LICENSEE shall incorporate and contain
the terms of Article XV of this Agreement.

                                ARTICLE XIV
                          PATENT MAINTENANCE FEES

   14.00  Pursuant to PATENT(S) and in the event that patents issue on
PATENT APPLICATIONS and IMPROVEMENTS, described herein, or other patents
subsequently issue related to the LICENSED PRODUCT and LICENSED TECHNOLOGY,
maintenance fees shall be paid by LICENSOR and not reimbursed by LICENSEE and
all documentation of payment shall be made available to the LICENSEE.
LICENSOR, upon request by LICENSEE, shall provide LICENSEE with records and
schedule of maintenance fee due dates.

                                 ARTICLE XV
                              NON-ASSIGNABILITY

   15.00  The parties agree that this agreement imposes obligations on
LICENSOR. The LICENSOR shall not assign any rights under this Agreement not
transferable by terms without the written consent of LICENSEE.  LICENSEE may
assign his rights hereunder without the consent of the LICENSOR.

                                ARTICLE XVI
                                SEVERABILITY

   16.00  The parties agree that if any part, term or provision of this
Agreement shall be found illegal or in conflict with any valid controlling
law, the validity of the remaining provisions shall not be affected thereby.

   16.01  In the event the legality of any provision of this agreement is
brought into question because of a decision by a court of competent
jurisdiction, LICENSOR, by written notice to LICENSEE, may revise the
provision in question or may delete it entirely so as to comply with the
decision of said court.

                               ARTICLE XVII
                        NON-USE OF LICENSOR'S NAME

   17.00  In publicizing anything used under this Agreement, LICENSOR shall
not use the name of LICENSEE or otherwise refer to any organization related
to LICENSEE, except with the written approval of LICENSEE.  LICENSOR is
authorized to make public the name of the LICENSEE and describe the
contractual relationship between the LICENSEE and LICENSOR if LICENSOR
becomes a publicly traded company and the disclosures are a requirement and
pursuant to the requirements of the Securities Act of 1933 or 1934.

                              ARTICLE XIII
                    WAIVER, INTEGRATION, ALTERATION

   18.00  The waiver of a breach hereunder may be affected only by a writing
signed by the waiving party and shall not constitute a waiver of any other
breach. APPLICATIONS and IMPROVEMENTS, PROPRIETARY INFORMATION, TRADE
SECRETS, TECHNICAL and SCIENTIFIC information, KNOW-HOW and registered
TRADEMARKS.

   18.02  A provision of this Agreement may be altered only by a writing
signed by both parties, except as provided in this Section.

                              ARTICLE XIV
                             APPLICABLE LAW

   19.00  This Agreement shall be constructed in accordance with the
substantive laws of the state of Nevada.

   19.01  The language under which this Agreement shall be interpreted,
arbitrated or litigated shall be English.

                              ARTICLE XX
                      NOTICES UNDER THE AGREEMENT

LICENSOR:
---------

EnzymeBioSystems
16773 W Park Drive
Chagrin Falls, Ohio, 44023

LICENSEE:
---------

Berkeley Clinic LC
P. O. Box 2742
Scottsdale, AZ  85252

or any other addresses of which either party shall notify the other party in
writing.

   IN WITNESS WHEREOF the parties have caused this Agreement to be executed
by their duly authorized officers and/or as an individual on the respective
dates and at the respective places hereinafter set forth.

LICENSEE:

Berkeley Clinic LC

By:    T J Jesky
       ---------------------
Title: T J Jesky
       Managing Member

LICENSOR:

EnzymeBioSystems

By:    Ashot Martirosyan
       ---------------------
Title: Ashot Martirosyan
       President

<PAGE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}]]